Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MCG.0000000000000566PMID 27306942PMCID PMC5154898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy

  2016cited by this paper
• Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis.

  2016cited by this paper
• The treatment of diabetes mellitus of patients with chronic liver disease.

  2015cited by this paper
• Relationship of hepatitis C virus infection with diabetes in the U.S. population

  2014cited by this paper
• Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new‐onset diabetes: A nationwide cohort study

  2014cited by this paper
• Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.

  2014cited by this paper
• Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C

  2014cited by this paper
• The relationship between hepatitis C virus infection and diabetes: Time for a divorce?

  2014cited by this paper
• Effect of type 2 diabetes on risk for malignancies included hepatocellular carcinoma in chronic hepatitis C

  2013cited by this paper
• Use of Administrative Claims Data for Identifying Patients with Cirrhosis

  2013cited by this paper
• Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C

  2013cited by this paper
• Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States

  2013cited by this paper
• Virus C Hepatitis and Type 2 Diabetes: A Cohort Study in Southern Italy

  2013cited by this paper
• The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease.

  2013cited by this paper
• The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007

  2012cited by this paper
• Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.

  2012cited by this paper
• Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

  2011cited by this paper
• Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

  2011cited by this paper
• Diagnosis, management, and treatment of hepatitis C: An update

  2009cited by this paper
• Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

  2009cited by this paper
• Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

  2008cited by this paper
• Insulin Resistance and Diabetes Increase Fibrosis in the Liver of Patients With Genotype 1 HCV Infection

  2008cited by this paper
• Relationship between hepatitis C virus infection and type 2 diabetes mellitus

  2008cited by this paper
• Genotype‐specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C

  2008cited by this paper
• Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis.

  2008cited by this paper
• Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.

  2007cited by this paper
• The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases

  2007cited by this paper
• Oral Glucose Tolerance Test Predicts Prognosis of Patients with Liver Cirrhosis

  2006cited by this paper
• The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

  2006cited by this paper
• Data Sources for Measuring Comorbidity: A Comparison of Hospital Records and Medicare Claims for Cancer Patients

  2006cited by this paper
• Insulin Resistance Plays a Significant Role in Liver Fibrosis in Chronic Hepatitis C and in the Response to Antiviral Therapy

  2005cited by this paper
• Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients.

  2005cited by this paper
• Validation of diagnostic codes within medical services claims.

  2004cited by this paper
• Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression

  2003cited by this paper
• Fibrogenic impact of high serum glucose in chronic hepatitis C.

  2003cited by this paper
• Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

  2003cited by this paper
• In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

  2003cited by this paper
• Contribution of obesity to hepatitis C-related fibrosis progression

  2002cited by this paper
• Development of a comorbidity index using physician claims data.

  2000cited by this paper
• [The prevalence of hepatitis C virus infection].

  1998cited by this paper
• Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

  1998cited by this paper
• Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease

  1998cited by this paper
• Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features

  1995cited by this paper
• Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade

  1993cited by this paper
• Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis

  1992cited by this paper
• Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States.

  1992cited by this paper
• Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

  1992cited by this paper
• HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS

  1991cited by this paper
• High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

  1991cited by this paper
• Non-A, non-B posttransfusion hepatitis--a decade later.

  1985cited by this paper

• Impact of overt and subclinical hepatogenous diabetes and metformin treatment on circulatory function, renal function and hemodynamics, inflammatory activity, and prognosis in patients with cirrhosis and ascites

  2025cites this paper
• Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C

  2025cites this paper
• Complications associated with HCV-related liver cirrhosis and their relationship with diabetic control. A tertiary care center study in Peshawar, Pakistan.

  2024cites this paper
• Der hepatogene Diabetes – aktueller Stand der Diagnostik und Therapie

  2022cites this paper
• Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives

  2022cites this paper
• Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype

  2022cites this paper
• Prevalence and Predictive Factors for Nosocomial Infection in the Military Hospitals: A Systematic Review and Meta-Analysis

  2021cites this paper
• Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis

  2020cites this paper
• Management of Diabetes Mellitus in Patients with Chronic Liver Diseases

  2019cites this paper
• Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data

  2019cites this paper
• The impact of hepatic steatosis on portal hypertension

  2019cites this paper
• Incidence and causes of mildly to moderately elevated aminotransferase in Japanese patients with type 2 diabetes

  2019cites this paper
• Comparison of demographic and virological profiles between diabetic and non-diabetic patients with cirrhosis of liver

  2019cites this paper
• Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis

  2019cites this paper
• The Burden of Chronic Hepatitis C in China From 2004 to 2050: An Individual‐Based Modeling Study

  2019cites this paper
• The Evaluation of Diabetes Mellitus as an Independent Risk Factor for Gastroesphageal Variceal Bleeding in Cirrhotic Patients

  2019cites this paper
• Asymptomatic chronic hepatitis c with F0-1 fibrosis: Wait and monitor

  2018cites this paper
• International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

  2017cites this paper
• САХАРНЫЙ ДИАБЕТ У ПАЦИЕНТОВ С ЦИРРОЗОМ ПЕЧЕНИ: НОВЫЕ ВОЗМОЖНОСТИ ЛЕЧЕНИЯ

  2017cites this paper